'Pharmaceutical Contract Sales Market Will Reach $3,912m in 2013' Predicts new Visiongain Report

'Pharmaceutical Contract Sales Market Will Reach $3,912m in 2013' Predicts new Visiongain Report PR Newswire LONDON, November 13, 2012 LONDON, November 13, 2012 /PRNewswire/ -- A new report by visiongain predicts that the global market for pharmaceutical contract sales will be worth $3,912m in 2013. Between 2011 and 2017, the worldwide market will grow with a CAGR of over 8%. Demand for outsourced sales teams will drive growth during this decade. Those findings and others appear in World Pharmaceutical Contract Sales Market 2013-2023, published in November 2012. Visiongain is a business information provider based in London, UK. Personal promotion will account for the largest proportion of pharma contract sales organisation (CSO) revenues throughout the 10-year forecast period. However, faster growth will come from other sectors of the contract sales market. Outsourcing of non-personal promotion will increase from 2012 to 2023, driven in the early years by greater use of teledetailing. Innovation and improvements to current technology will provide greater opportunities for virtual detailing. In 2023, outsourced edetailing will account for close to $200m in CSO revenues, the report shows. Richard Lang, a pharmaceutical industry analyst for visiongain, said: "Pharmaceutical sales models are changing rapidly. Healthcare payers have greater influence in prescribing decisions, complicating market access strategies for pharmaceutical companies.